Webinar: Relapsed Follicular Lymphoma – Essential Insights
This inspiring session on Relapsed FL, which took place on September 26th 2024, provided the audience with valuable expert discussion and a patient perspective.
$2.25 Million to Research United to CURE Follicular Lymphoma
This strategic alliance with LLS and IFLI will further accelerate pioneering research and help cure follicular lymphoma through our Research United to CURE FL program.
Latest follicular lymphoma research updates from recent scientific conferences
The team updates from recent scientific conferences on the latest research in follicular lymphoma, from cutting-edge therapies to genetic insights.
Webinar: Understanding Follicular Lymphoma Clinical Trials
View our webinar focused on sharing experiences and improving understanding of clinical trials.
South West Coast 50 Ultra Challenge
Challenge yourself with the South West Coast 50 Ultra Challenge on Saturday 3rd August.
Don’s story
My name is Don, and I am 68 years old. I live in Phoenix, Arizona and am married. The picture is of me aged 25 on a cross country bike ride.
What is the potential for minimal residual disease in follicular lymphoma treatment?
Minimal/measurable residual disease refers to the small number of cancer cells remaining in the body after treatment.
Immunotherapy: Can we make better CAR-Ts and bispecific antibodies?
How do we improve immunotherapy treatments to ensure long-lasting effectiveness, fewer side effects, and ensure they are accessible?
Michaela’s story
My name is Michaela, and I am a 55 year old trans woman living in England. I was diagnosed in 2018 and been in remission for 5 years.
Immunotherapy: A breakthrough in follicular lymphoma treatmentÂ
Dr Mitchell Smith, FLF CMO, explains Immunotherapy and what it means for people living with follicular lymphoma in terms of treatment.